Settings
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E17.57 EPS (ttm)5.70 Insider Own0.01% Shs Outstand2.80B Perf Week-2.02%
Market Cap280.30B Forward P/E15.27 EPS next Y6.56 Insider Trans-11.10% Shs Float2.80B Perf Month-4.95%
Income16.32B PEG3.22 EPS next Q1.53 Inst Own67.40% Short Float1.07% Perf Quarter-4.52%
Sales74.33B P/S3.77 EPS this Y18.50% Inst Trans-0.15% Short Ratio3.68 Perf Half Y1.39%
Book/sh26.92 P/B3.72 EPS next Y5.59% ROA15.80% Target Price109.72 Perf Year14.98%
Cash/sh11.79 P/C8.49 EPS next 5Y5.46% ROE27.60% 52W Range83.76 - 108.99 Perf YTD-4.24%
Dividend2.80 P/FCF- EPS past 5Y5.30% ROI17.70% 52W High-8.12% Beta0.58
Dividend %2.80% Quick Ratio2.20 Sales past 5Y3.70% Gross Margin69.40% 52W Low19.55% ATR1.81
Employees126500 Current Ratio2.60 Sales Q/Q-0.60% Oper. Margin32.80% RSI (14)37.05 Volatility1.64% 1.62%
OptionableYes Debt/Eq0.20 EPS Q/Q-27.60% Profit Margin28.30% Rel Volume1.31 Prev Close102.38
ShortableYes LT Debt/Eq0.17 EarningsJan 20 BMO Payout37.00% Avg Volume8.15M Price100.14
Recom2.50 SMA20-3.26% SMA50-4.94% SMA200-2.57% Volume10,671,010 Change-2.19%
Dec-08-14Reiterated RBC Capital Mkts Outperform $110 → $114
Jul-16-14Reiterated Deutsche Bank Hold $102 → $107
Apr-17-14Reiterated Argus Buy $104 → $116
Apr-16-14Reiterated RBC Capital Mkts Outperform $104 → $106
Jan-10-14Downgrade Barclays Overweight → Equal Weight $99
Jan-07-14Upgrade RBC Capital Mkts Sector Perform → Outperform $88 → $104
Dec-16-13Reiterated Deutsche Bank Hold $93 → $95
Jul-18-13Reiterated Argus Buy $96 → $104
Jul-17-13Reiterated Barclays Overweight $95 → $99
Jul-17-13Downgrade Deutsche Bank Buy → Hold $92 → $93
Apr-18-13Reiterated Argus Buy $80 → $96
Apr-15-13Reiterated Barclays Overweight $85 → $95
Apr-12-13Reiterated Deutsche Bank Buy $82 → $87
Mar-26-13Reiterated UBS Buy $81 → $87
Jan-11-13Reiterated UBS Buy $76 → $78
Jan-04-13Upgrade Deutsche Bank Hold → Buy $75 → $82
Nov-20-12Initiated Stifel Nicolaus Hold
Jul-18-12Reiterated RBC Capital Mkts Sector Perform $65 → $71
Apr-18-12Reiterated UBS Buy $71 → $70
Dec-12-11Reiterated UBS Buy $72 → $69
Jan-30-15 05:55PM  Pharmacyclics Up on Imbruvica Label Expansion in the U.S. - Analyst Blog Zacks
04:50PM  Another absolutely wild day on Wall Street Yahoo Finance Contributors
11:39AM  Valeant Agrees To Buy Dendreon's Provenge at Investor's Business Daily
10:04AM  AbbVie reports better-than-expected 4Q on Humira sales AP
Jan-29-15 12:43PM  Novartis and J&J back UK biotech working on 30-minute STD test at Financial Times
11:29AM  FDA expands use of Imbruvica to treat rare form of cancer Reuters
07:06AM  Reputation Management With Digital And Social Media at Forbes
Jan-28-15 03:31PM  AmerisourceBergen's Revenue Growth May Slow Further at Investor's Business Daily
11:32AM  The most important thing to look for in Amazons earnings at MarketWatch
Jan-27-15 05:29PM  US company outlooks worry investors, sending stocks lower AP
04:50PM  US STOCKS-Wall St falls 1 pct on earnings; Apple rallies late Reuters
04:20PM  US STOCKS-Wall St ends down 1 pct on Caterpillar, Microsoft earnings Reuters
02:55PM  Zosano Pharma raises $50M after IPO hits target at American City Business Journals
08:00AM  Depression Drug That Works In One Day Passes Key Test at Forbes
Jan-26-15 04:45PM  CytRx Candidate Encourages in Soft Tissue Sarcoma Study - Analyst Blog Zacks
04:06PM  J&J Snack Foods posts 1Q profit AP
01:15PM  Jim Cramer Answers Twitter (TWTR) Questions on Johnson & Johnson, Alcoa, Mobileye, and Facebook at TheStreet
10:50AM  AstraZeneca's Regulatory Filing for Lesinurad Accepted - Analyst Blog Zacks
10:06AM  Pharmaceutical industry regulations Market Realist
09:30AM  The Zacks Analyst Blog Highlights: American Express, IBM, Johnson & Johnson, UnitedHealth Group and Travelers - Press Releases Zacks
Jan-23-15 05:20PM  Minerva Neurosciences Gains on Positive Data on MIN-202 - Analyst Blog Zacks
04:55PM  Stocks mostly fall, curbing first weekly advance in 4 at CNBC
04:16PM  Dow 30 Stock Roundup: AmEx, UnitedHealth Beat, IBM Earnings Fall Y/Y - Analyst Blog Zacks
04:06PM  Pharmaceutical industry supply chain Market Realist
11:36AM  Three More FIFA Sponsors Wont Renew With Soccer Authority at Bloomberg
11:26AM  Plaintiffs' lawyers reject J&J claims of fraud in mesh lawsuits Reuters
05:53AM  3 FIFA sponsors won't renew for 2018 World Cup in Russia AP
01:00AM  First GSK Ebola vaccine shipment due to arrive in Liberia Reuters
Jan-22-15 08:55PM  J&Js Foes Say Phone Solicitations Didnt Taint Mesh Suits at Bloomberg
06:13PM  Cramer: Collateral damage of the euro in the US at CNBC
06:00PM  Cramer: Domestic's working CNBC
06:00PM  Cramer: Avoid stocks getting crushed by this CNBC
05:40PM  Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog Zacks
01:39PM  This is what a currency war looks like CNBC
01:13PM  3 reasons the ECB stimulus matters at CNNMoney.com
01:00PM  Natus Medical's a Strong Buy on Expanding Product Portfolio - Analyst Blog Zacks
12:00PM  Judge to decide if Boston Scientific should pay $7.2B to Johnson & Johnson at American City Business Journals
11:54AM  Morgan Stanley Analyst Sees FY15 'Trough' For Johnson & Johnson Pharma Growth Benzinga
11:02AM  Covidien Q1 Earnings Beat Estimates As Buyout Nears at Investor's Business Daily
09:01AM  Cramer: US rates all over map CNBC
12:03AM  MBA Students: Choose Your First Marketing Job Wisely at Forbes
Jan-21-15 10:50PM  J&J Seeks Billions in Trial Over Decade-Old Bidding War at Bloomberg
07:36PM  J&J's $7.2 bln claim against Boston Scientific now with U.S. judge Reuters
06:17PM  Bayer Announces Updates to European Label of Xarelto - Analyst Blog Zacks
01:14PM  Drugs Path to China Slows as Regulatory Delays Add Up, J&J Says at Bloomberg
01:00PM  Healthcare ETFs in Focus on Mixed JNJ Results - ETF News And Commentary Zacks
09:00AM  Dr. Paul Janssen Award for Biomedical Research Issues 2015 Call for Nominations PR Newswire
08:19AM  The Promise Of Financial Return Is Driving Both The "Biotech Bubble" And Orphan Drugs at Forbes
Jan-20-15 10:59PM  Most Asian stocks higher as investors await ECB decision AP
07:00PM  Cramer on Netflix after the big news CNBC
06:12PM  Evotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog Zacks
06:06PM  Johnson & Johnson's forex warning a sign for rival drugmakers Reuters
06:03PM  Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog Zacks
06:00PM  Cramer: Don't let bad news bears fake you out CNBC
05:40PM  Stock Pops & Drops: SAP, SWHC, JCP & JNJ CNBC
05:07PM  Top Ten Stock for Jan. 20 at Bloomberg
04:49PM  Tuesday's Market Recap Yahoo Finance Blogs
04:19PM  Taking Stock: Winners and Losers, Stock of the Day at Bloomberg
04:19PM  Stocks cut losses, close higher; oil tumbles at USA TODAY
04:01PM  Market bright spots CNBC
02:47PM  Johnson & Johnson (JNJ) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
02:44PM  Johnson & Johnson tops 4Q earnings expectations AP
02:39PM  What to Watch in the Day Ahead - Wednesday, Jan. 21 Reuters
01:26PM  J&J Sales Dented by Stronger Dollar at The Wall Street Journal
01:24PM  Stocks decline with price of oil; J&J disappoints at CNBC
12:19PM  Tue., Jan. 20: Watch Twitter on India Deal at MarketWatch
11:55AM  J&J Beats on Q4 Earnings, Revenues Hit by Currency - Analyst Blog Zacks
11:20AM  J&J Earnings Beat But Sales, Guidance Miss at Investor's Business Daily
11:00AM  J&J Faces Headwinds in 2015 Morningstar
10:25AM  Johnson & Johnson's Fourth Quarter Sales Got Whacked By Currencies Business Insider
10:10AM  Stock Market News for January 20, 2015 - Market News Zacks
10:07AM  Johnson & Johnson (JNJ) Stock Falls Today After Lowering 2015 Earnings Forecast at TheStreet
09:50AM  IMF Cuts, Q4 Earnings Mixed - Ahead of Wall Street Zacks
09:48AM  Johnson & Johnson Facing Headwinds From A Stronger Dollar at Forbes
09:46AM  Stocks to Watch: Morgan Stanley, J&J, Halliburton at The Wall Street Journal
09:45AM  Johnson & Johnson beats fourth quarter estimates at USA TODAY
09:38AM  Morgan Stanley Misses on Q4 Earnings at MarketWatch
09:28AM  Cramer's Mad Dash: DAL & TIF CNBC
09:15AM  Stronger dollar hurts J&J's quarterly sales Reuters
09:01AM  Morgan Stanley slips on miss; Halliburton jumps on beat; J&J mixed results Yahoo Finance
09:00AM  J&J (JNJ) Beats on 4Q Earnings but Misses on Revenues - Tale of the Tape Zacks
08:55AM  East Bay's Depomed snags J&J pain-fighting drug in $1 billion deal at American City Business Journals
08:30AM  Johnson & Johnson Barely Pulls Through on Strong Pharma Sales at 24/7 Wall St.
08:16AM  JOHNSON & JOHNSON Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online
08:01AM  Updates, advisories and surprises at MarketWatch
08:00AM  J&J's profit beats estimates on sales of new drugs Reuters
07:59AM  Johnson & Johnson beats profit expectations, but sales fall shy at MarketWatch
07:57AM  Johnson & Johnson Earnings Beat Estimates on Prescription Sales at Bloomberg
07:51AM  Johnson & Johnson beats 4Q profit forecasts AP
07:45AM  Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results: PR Newswire
07:42AM  Wall Street set for strong open; Google invests in SpaceX; Facebook's global economic impact Yahoo Finance
07:07AM  Q4 2014 Johnson & Johnson Earnings Release - Before Market Open CCBN
Jan-19-15 07:52PM  Johnson and Johnson Posts Fourth-Quarter EPS Beat at Fox Business
06:44PM  Ebola Vaccine Sends Johnson & Johnson Stock Higher Ahead of Earnings at TheStreet
11:40AM  Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog Zacks
09:49AM  Q4 Earnings Take a Breather for MLK Day - Ahead of Wall Street Zacks
07:00AM  10 Biggest Deals Involving Venture Capital-Backed Companies in 2014 at TheStreet
Jan-18-15 09:01AM  Earnings, ECB highlight holiday-shortened week at MarketWatch
Jan-16-15 06:22PM  Johnson & Johnson Ebola groups get $117M in funding AP
04:34PM  U.S. markets break 5-day losing streak Yahoo Finance Blogs
Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COSGROVE STEPHEN JCorporate ControllerJan 16Option Exercise0.0011,1080101,402Jan 21 05:48 PM
Ullmann Michael HVP, General CounselJan 16Option Exercise0.008,949075,628Jan 21 05:48 PM
Caruso Dominic JVP, Finance; CFOJan 16Option Exercise0.0012,615074,216Jan 21 05:48 PM
Gorsky AlexChairman, CEOJan 16Option Exercise0.0016,845094,425Jan 21 05:48 PM
Stoffels PaulusChief Scientific OfficerJan 16Option Exercise0.0011,629039,539Jan 21 05:48 PM
Fasolo PeterVP, Global Human ResourcesJan 16Option Exercise0.008,374024,336Jan 21 05:48 PM
PETERSON SANDRA EGroup Worldwide ChairmanDec 17Option Exercise0.0021,689031,210Dec 19 04:37 PM
JOHNSON & JOHNSON10% OwnerNov 12Buy18.0040,000720,0003,077,005Nov 12 03:06 PM
COSGROVE STEPHEN JCorporate ControllerNov 05Option Exercise66.182,490164,78892,784Nov 07 04:49 PM
COSGROVE STEPHEN JCorporate ControllerNov 05Sale108.552,490270,29390,294Nov 07 04:49 PM
CULLEN JAMESDirectorSep 10Sale104.122,446254,6721,489Sep 11 02:19 PM
Caruso Dominic JVP, Finance; CFOAug 21Option Exercise66.1830,0001,985,40091,600Aug 25 04:35 PM
Caruso Dominic JVP, Finance; CFOAug 21Sale104.3030,0003,129,06961,600Aug 25 04:35 PM
COSGROVE STEPHEN JCorporate ControllerMay 05Option Exercise66.1822,0001,455,960112,294May 06 06:10 PM
COSGROVE STEPHEN JCorporate ControllerMay 05Sale100.0522,0002,201,10090,294May 06 06:10 PM
JOHNSON & JOHNSON10% OwnerMay 01Option Exercise5.1672,690375,0801,773,730May 05 02:19 PM
COSGROVE STEPHEN JCorporate ControllerApr 25Option Exercise66.181,51099,93291,293Apr 28 05:03 PM
Fasolo PeterVP, Global Human ResourcesMar 14Sale93.156,824635,64015,647Mar 17 06:10 PM
Fasolo PeterVP, Global Human ResourcesMar 04Option Exercise62.6644,8612,811,19243,571Mar 05 06:18 PM